Table 4 Effects of L-carnitine supplementation on cardiac parameters
Variables | Before | 6 months |
|---|---|---|
Systolic blood pressure (mmHg) | 156.6 ± 3.4 | 155.0 ± 2.9 |
Diastolic blood pressure (mmHg) | 76.6 ± 3.2 | 73.4 ± 2.9 |
Antihypertensive medication | ||
Diuretics (%) | 23.8 | 19.0 |
α-blocker (%) | 4.8 | 4.8 |
β-blocker (%) | 23.8 | 23.8 |
Calcium antagonist (%) | 42.9 | 42.9 |
Angiotensin II type 1 receptor blocker (%) | 47.6 | 52.4 |
M-mode echocardiography | ||
EF (%) | 69.1 ± 10.8 | 69.8 ± 10.5 |
FS (%) | 42.2 ± 11.4 | 46.1 ± 9.8** |
LVDd (cm) | 4.5 ± 0.9 | 4.6 ± 0.8 |
LVDs (cm) | 2.6 ± 0.9 | 2.5 ± 0.8 |
IVS (mm) | 14 ± 3 | 15 ± 3 |
LVPW (cm) | 1.4 ± 0.2 | 1.3 ± 0.3 |
LVM (g) | 308.2 ± 131.1 | 303.5 ± 104.4 |
LVMI (g/m2) | 217.8 ± 100.2 | 212.3 ± 77.3 |
Chest X-ray | ||
CTR (%) | 52.8 ± 5.3 | 52.4 ± 5.0 |
Laboratory data | ||
BNP (pg/mL) | 621.4 ± 666.8 | 412.0 ± 426.0* |